When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Sci China Life Sci. 2024 May;67(5):854-864. doi: 10.1007/s11427-023-2446-y. Epub 2024 Jan 19.

Abstract

Tobacco smoking is a prevalent and detrimental habit practiced worldwide, increasing the risk of various diseases, including chronic obstructive pulmonary disease (COPD), cardiovascular disease, liver disease, and cancer. Although previous research has explored the detrimental health effects of tobacco smoking, recent studies suggest that gut microbiota dysbiosis may play a critical role in these outcomes. Numerous tobacco smoke components, such as nicotine, are found in the gastrointestinal tract and interact with gut microbiota, leading to lasting impacts on host health and diseases. This review delves into the ways tobacco smoking and its various constituents influence gut microbiota composition and functionality. We also summarize recent advancements in understanding how tobacco smoking-induced gut microbiota dysbiosis affects host health. Furthermore, this review introduces a novel perspective on how changes in gut microbiota following smoking cessation may contribute to withdrawal syndrome and the degree of health improvements in smokers.

Keywords: gut microbiota dysbiosis; nicotine; smoking cessation; tobacco smoking.

Publication types

  • Review

MeSH terms

  • Animals
  • Dysbiosis* / microbiology
  • Gastrointestinal Microbiome*
  • Gastrointestinal Tract / microbiology
  • Humans
  • Nicotine / adverse effects
  • Nicotine / metabolism
  • Pulmonary Disease, Chronic Obstructive / etiology
  • Pulmonary Disease, Chronic Obstructive / microbiology
  • Smoking Cessation
  • Tobacco Smoking* / adverse effects

Substances

  • Nicotine